Neautus looks outward to boost its traditional medicine story
The maker of traditional Chinese medicines has applied for a Hong Kong IPO after abandoning two listing attempts on China’s domestic A-share market Key Takeaways: Neautus has applied to list…
BRIEF: Ping An Healthcare records first annual profit
Ping An Healthcare and Technology Co. Ltd. (1833.HK) on Wednesday reported its revenue rose 2.9% last year to 4.81 billion yuan ($665 million), as it ended years of losses to…
BRIEF: Concord Healthcare ties with Mayo Clinic to improve management
Medical services provider Concord Healthcare Group Co. Ltd. (2453.HK) said Thursday it has entered into an agreement for Mayo Foundation, operator of the Mayo Clinic, to provide it with consulting…
BRIEF: Wai Yuen Tong profit rises six-fold on non-operational gains
Drug and healthcare products maker Wai Yuen Tong Medicine Holdings Ltd. (0897.HK) announced on Wednesday its revenue fell 5.8% year-on-year to HK$347 million ($45 million) in the six months to…
INDUSTRY BRIEF: China relaxes rules for foreign investment in hospitals
China has unveiled a pilot program to encourage more foreign investment in the country’s hospitals, allowing foreigners to fully own medical facilities in eight cities, including Beijing and Shanghai, Caixin…
Inaugural operating profit fails to lift 111 Inc.
The drug distributor expects to benefit from an ongoing crackdown on corruption in its industry due to the company’s focus on distribution to pharmacies rather than hospitals Key Takeaways: 111…
FAST NEWS: EUDA Health to merge with developer of cancer, women’s health treatments
The Latest: Singapore-based digital health platform EUDA Health Holdings Ltd. (EUDA.US) said on Thursday it has signed a letter of intent to merge with TheoremRx Inc., a U.S.-based developer of…
Recent Articles
RELATED ARTICLES
-
Cancer drug maker Genfleet joins Hong Kong IPO influx
-
Cancer drug maker Biostar shines on Hong Kong market debut
2563.HK
-
A blockbuster cancer drug? TYK’s claims go under the microscope
2410.HK
-
Everest Medicines drives growth with AI-powered mRNA pipeline
1952.HK
-
Earnings blow for CSPC Pharma as the state drives a hard bargain
1093.HK
-
After a failed Fosun buyout, what’s next for drug maker Henlius Biotech?
2696.HK
